Future Vision II Acquisition Corp. - Common Shares (FVN)

CUSIP: G37068106

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Shares
Shares outstanding
7,531,045
Total 13F shares
4,843,147
Share change
+11,868
Total reported value
$49,260,185
Price per share
$10.18
Number of holders
24
Value change
+$203,209
Number of buys
9
Number of sells
9

Sponsored

Quarterly Holders Quick Answers

What is CUSIP G37068106?
CUSIP G37068106 identifies FVN - Future Vision II Acquisition Corp. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Future Vision II Acquisition Corp. - Common Shares (FVN) as of Q1 2025

As of 31 Mar 2025, Future Vision II Acquisition Corp. - Common Shares (FVN) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,843,147 shares. The largest 10 holders included MIZUHO SECURITIES USA LLC, Karpus Management, Inc., TORONTO DOMINION BANK, RIVERNORTH CAPITAL MANAGEMENT, LLC, AQR Arbitrage LLC, HEIGHTS CAPITAL MANAGEMENT, INC, ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, GLAZER CAPITAL, LLC, and Westchester Capital Management, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
25
Q1 2025 holders
24
Holder diff
-1
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.